Madrigal Pharmaceuticals Ownership & Insider Activity

Madrigal Pharmaceuticals (MDGL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 39.6% of shares outstanding. Institutional investors hold 55.2%. Over the past 90 days, insiders made 2 sales worth $859K.

Shares Outstanding

23.104M

Shares Float

19.656M

Insider Shares Owned

9.142M

Insider % Owned

39.6%

Institutional Shares Held

12.758M

Institutional % Held

55.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$859K total

Net Activity

Net Selling

Net Value (90d)

-$859K

Madrigal Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 17, 2026	Shannon Kelley	GENERAL COUNSEL	SELL	664.000	$514.97	$342K
Jul 17, 2026	John William Sibold	PRESIDENT AND CEO	SELL-OPTIONS	47.500K	$547.30	$1.4M
Jun 1, 2026	David Soergel	CHIEF MEDICAL OFFICER	SELL	1.042K	$495.74	$517K
May 22, 2026	Richard Levy	DIRECTOR	SELL	5.682K	$515.44	$2.9M
May 18, 2026	David Soergel	CHIEF MEDICAL OFFICER	SELL	844.000	$515.90	$435K
Mar 6, 2026	Rebecca Taub	DIRECTOR	SELL	491.000	$431.94	$212K
Mar 4, 2026	Mardi Dier	EVP AND CFO	GRANT	3.233K	$430.87	$854K
Mar 4, 2026	John William Sibold	PRESIDENT AND CEO	GRANT	13.332K	$431.94	$718K
Mar 4, 2026	Shannon Kelley	GENERAL COUNSEL	GRANT	3.657K	$431.94	$155K
Mar 4, 2026	Carole Huntsman	CHIEF COMMERCIAL OFFICER	GRANT	3.570K	$431.94	$181K
Mar 2, 2026	Mardi Dier	EVP AND CFO	SELL	1.183K	$427.21	$505K

Date	Member	Party	Chamber	Action	Amount
Apr 10, 2023	Daniel Goldman	D	House	S	$1,001 - $15,000